Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.
Surveillance of HIV infection by voluntary testing in England.
Commun Dis Rep CDR Rev. 1992 Jul 17;2(8):R85-90. Unique Identifier : AIDSLINE MED/94061126 Waight PA; Rush AM; Miller E
Abstract:
Eighteen laboratories, which together provide primary HIV antibody testing for 43% of the population in England, collaborated in a study to record epidemiological information for all individuals voluntarily tested by them over a five year period. From the 184,113 individuals who had a first test during the study period, it is estimated that 1 in 12 adults in London, and 1 in 50 outside London have been voluntarily tested for HIV since testing became widely available in 1985. The majority of those tested were individuals whose perceived risk was heterosexual exposure. Infection in this group was concentrated in individuals whose partner had an identified risk and in those who had lived in or visited Africa. The rise in antibody prevalence observed in the latter group during 1990/91 may have been partly due to infection recently acquired in the UK. Antibody prevalence in heterosexuals without a high risk partner or a history of exposure abroad also rose during the study period, suggesting a recent increase in transmission through casual heterosexual exposure in the UK. The study also provided strong evidence of continuing high risk behaviour among homosexual men, particularly in the younger age groups. Homosexuals aged under 30 years and living in London had the greatest risk of acquiring HIV infection since 1988.
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/TRANSMISSION Adolescence Adult AIDS Serodiagnosis/*STATISTICS & NUMER DATA England/EPIDEMIOLOGY Female Human HIV Infections/*EPIDEMIOLOGY/TRANSMISSION HIV Seroprevalence/*TRENDS Male Middle Age *Population Surveillance Risk Factors Sexual Partners JOURNAL ARTICLE 940330
M9431001
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.
